XML 26 R17.htm IDEA: XBRL DOCUMENT
v3.23.3

Net Income (Loss) per Share Attributable to Common Stockholders | 9 Months Ended
--- | ---
Oct. 31, 2023
Earnings Per Share [Abstract] |
Net Income (Loss) per Share Attributable to Common Stockholders | Net Income (Loss) per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net income (loss) per share attributable to common stockholders for periods presented:
| Three Months Ended October 31, |  | Nine Months Ended October 31,
(in thousands, except per share data) | 2023 |  | 2022 |  | 2023 |  | 2022
Numerator: |  |  |  |  |  |  |
Net income (loss) attributable to common stockholders, basic | $ | 38,805 |  |  | $ | (29,866) |  |  | $ | 46,739 |  |  | $ | (102,317) |
Add: Interest expense on convertible senior notes | 22 |  |  | — |  |  | 425 |  |  | — |
Net income (loss) attributable to common stockholders, diluted | $ | 38,827 |  |  | $ | (29,866) |  |  | $ | 47,164 |  |  | $ | (102,317) |
Denominator: |  |  |  |  |  |  |
Weighted-average common shares outstanding, basic | 204,456 |  |  | 201,393 |  |  | 203,609 |  |  | 200,569 |
Effect of dilutive securities | 3,598 |  |  | — |  |  | 4,708 |  |  | — |
Weighted-average common shares outstanding, diluted | 208,054 |  |  | 201,393 |  |  | 208,317 |  |  | 200,569 |
Net income (loss) per share attributable to common stockholders: |  |  |  |  |  |  |
Basic | $ | 0.19 |  |  | $ | (0.15) |  |  | $ | 0.23 |  |  | $ | (0.51) |
Diluted | $ | 0.19 |  |  | $ | (0.15) |  |  | $ | 0.23 |  |  | $ | (0.51) |
Outstanding potentially dilutive securities that were excluded from the diluted per share calculations because they would have been antidilutive are as follows:
| Three Months Ended October 31, |  | Nine Months Ended October 31,
(in thousands) | 2023 |  | 2022 |  | 2023 |  | 2022
RSUs | 22,913 |  |  | 15,201 |  |  | 13,045 |  |  | 15,201 |
Stock options | — |  |  | 2,340 |  |  | — |  |  | 2,340 |
ESPP | — |  |  | 551 |  |  | — |  |  | 551 |
Convertible senior notes | — |  |  | 2,161 |  |  | — |  |  | 2,161 |
Total antidilutive securities | 22,913 |  |  | 20,253 |  |  | 13,045 |  |  | 20,253 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration